Comparative cytogenetic and DNA flow cytometric analysis of 242 primary breast carcinomas

Cancer Genetics and Cytogenetics

Volumn 147, Issue 1, 2003, Pages 62-67

  Adeyinka, Adewale ^a   Baldetorp, Bo ^a   Mertens, Fredrik ^a   Olsson, Håkan ^a   Johannsson, Oskar ^a   Heim, Sverre ^c   Pandis, Nikos ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b SAINT SAVVAS HOSPITAL   (Greece)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ARTICLE; BREAST CARCINOMA; CANCER GENETICS; CELL CYCLE S PHASE; CELL POPULATION; CHROMOSOME 20; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME ARM; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOGENETICS; DIPLOIDY; DNA DETERMINATION; FLOW CYTOMETRY; GENETIC ANALYSIS; GENOME ANALYSIS; HUMAN; HUMAN CELL; POLYSOME; PRIORITY JOURNAL;

EID: 0142217431     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00190-0     Document Type: Article

References (31)

1. Pandis N., Bardi G., Heim S. Interrelationship between methodological choices and conceptual models in solid tumor cytogenetics. Cancer Genet Cytogenet. 76:1994;77-84.
2. Steinarsdóttir M., Pétursdóttir I., Snorradóttir S., Eyfjörd J.E., Ögmundsdóttir H.M. Cytogenetic studies of breast carcinomas: different karyotypic profiles detected by direct harvesting and short-term culture. Genes Chromosomes Cancer. 13:1995;239-248.
3. Alvegård T.A., Berg N.O., Baldetorp B., Fernö M., Killander D., Ranstam J., Rydholm A., Åkerman M. Cellular DNA content and prognosis of high-grade soft tissue sarcoma. The Scandinavian Sarcoma Group experience. J Clin Oncol. 8:1990;538-547.
4. Remvikos Y., Gerbault-Seurreau M., Vielh P., Zafrani B., Magdelénat H., Dutrillaux B. Relevance of DNA ploidy as a measure of genetic deviation: a comparison of flow cytometry and cytogenetics in 25 cases of human breast cancer. Cytometry. 9:1988;612-618.
5. Lópéz-Ginés C., Callaghan R.C., Ruiz A., Gil R., Pellín A., Calderón J., Vazquez C., Llombart-Bosch A. Cytogenetics, flow cytometry, cytophotometry and morphometry of 22 cases of primary breast carcinoma. A comparative study. Virchows Arch B Cell Pathol. 61:1991;133-140.
6. Steinarsdóttir M., Jónasson J.G., Pétursdó ttir I., Sigurdsson H., Ögmundsdóttir H.M. A comparison of cytogenetic studies and flow cytometry in breast carcinomas. Cytometry. 28:1997;323-328.
7. Petersen S.E., Friedrich U. A comparison between flow cytometric ploidy investigation and chromosome analysis of 32 human colorectal tumors. Cytometry. 7:1986;307-312.
8. Tribukait B., Granberg-Öhman I., Wijkstöm H. Flow cytometric DNA and cytogenetic studies in human tumors: a comparison and discussion of the differences in modal values obtained by the two methods. Cytometry. 7:1986;194-199.
9. Bratt O., Anderson H., Bank-Jesen E., Baldetorp B., Lundgren R. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence in prognosis. Urology. 2:1996;218-224.
10. Dressler L.G., Duncan M.H., Varsa E.E., Macconnell T.S. DNA content measurement can be obtained using archival material for DNA flow cytometry. A comparison with cytogenetic analysis in 56 pediatric solid tumors. Cancer. 72:1993;2033-2041.
11. Mandahl N., Baldetorp B., Fernö M., Åkerman M., Rydholm A., Heim S., Willén H., Killander D., Mitelman F. Comparative cytogenetic and DNA flow cytometry analysis of 150 bone and soft-tissue tumors. Int J Cancer. 53:1993;358-364.
12. Pandis N., Heim S., Bardi G., Limon J., Mandahl N., Mitelman F. Improved technique for short-term culture and cytogenetic analysis of human breast cancer. Genes Chromosomes Cancer. 5:1992;14-20.
13. Mitelman F. An international system for human cytogenetic nomenclature. 1995;S. Karger, Basel.
14. Pandis N., Idvall I., Bardi G., Jin Y., Gorunova L., Mertens F., Olsson H., Ingvar C., Beroukas K., Mitelman F., Heim S. Correlation between karyotypic pattern and clinicopathologic features in 125 breast cancer cases. Int J Cancer. 66:1996;191-196.
15. Adeyinka A., Mertens F., Idvall I., Bondesson L., Ingvar C., Mitelman F., Pandis N. Different patterns of chromosomal imbalances in metastasising and non-metastasising primary breast carcinomas. Int J Cancer. 84:1999;370-375.
16. Baldetorp B., Dalberg M., Holst U., Lindgren G. Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm. Cytometry. 10:1989;695-705.
17. Baldetorp B., Fernö M., Fallenius A., Fallenius-Vecchi G., Idvall I., Olsson H., Sigurdsson H., Åkerman A., Killander D. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry. Cytometry. 13:1992;577-585.
18. Baisch H., Gohde W., Linden W.A. Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle. Radiat Environ Biophys. 12:1975;31-39.
19. Baldetorp B., Bendahl P.O., Fernö M., Alanen K., Delle U., Falkmer U., Hansson-Aggesjo B., Hockenstrom T., Lindgren A., Mossberg L., Nordling S., Sigurdsson H., Stål O., Visakorpi T. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates. Cytometry. 22:1995;115-127.
20. Coon J.S., Schwartz D., Summers J.L., Miller A.W., Weistein R.S. Flow cytometric analysis of deparaffinized nuclei in urinary bladder carcinoma. Comparison with cytogenetic analysis. Cancer. 57:1986;1595-1601.
21. Smeets A.W.G.B., Pauwels R.P.E., Beck J.L.E., Beck J.L.M., Geraedts J.P.M., Debruyne F.M.J., Laarakkers L., Feitz W.F.J., Voous G.P., Ramaaekers F.C.S. Tissue-specific markers in flow cytometry of urological cancers III. Comparing chromosomal and flow cytometry DNA analysis of bladder tumors. Int J Cancer. 39:1987;304-310.
22. Shackney S.E., Burholt D.R., Pollice A.A., Smith C.A., Pugh R.P., Hartsock J.R. Discrepancies between flow cytometric and cytogenetic studies in the detection of aneuploidy in human solid tumors. Cytometry. 11:1990;94-104.
23. Vindeløv L.L., Christensen I.J., Jensen G., Nissen N.I. Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample-storage, staining and internal standardization. Cytometry. 3:1983;332-339.
24. O'Reilly S.M., Richards M.A. Is DNA flow cytometry a useful investigation in breast cancer? Eur J Cancer. 28:1992;504-507.
25. Teixeira M.R., Pandis N., Bardi G., Andersen J.A., Mitelman F., Heim S. Clonal heterogeneity in breast cancer: karyotypic comparisons of multiple intra- and extra-tumorous samples from 3 patients. Int J Cancer. 63:1995;63-68.
26. Wenger R.C., Clark G.M. S-phase fraction and breast cancer- a decade of experience. Breast Cancer Res Treat. 51:1998;255-265.
27. Pandis N., Jin Y., Gorunova L., Petersson C., Bardi G., Idvall I., Johansson B., Ingvar C., Mandahl N., Mitelman F., Heim S. Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosomes Cancer. 12:1995;173-185.
28. Isola J., Kallioniemi O.-P., Chu L.W., Fuqua S.A.W., Hilsenbec S.G., Osborne K.C., Waldman F.M. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol. 147:1995;905-911.
29. Tanner M.M., Tirkkonen M., Kallioniemi M., Holli K., Collins C., Kowbel D., Gray J.W., Kallioniemi O.P., Isola J. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Clin Cancer Res. 1:1995;1455-1461.
30. Hansen L.L., Yilmaz M., Overgaard J., Andersen J., Kruse T.A. Allelic loss of 16q232-242 is an independent marker of good prognosis in primary breast cancer. Cancer Res. 58:1998;2166-2169.
31. Tsuda H., Takarabe T., Fukutomi T., Hirohashi S. der(16)t(1;16)/der(1;16) in breast cancer detected by fluorescence in situ hybridization is an indicator of better prognosis. Genes Chromosomes Cancer. 24:1999;72-77.